73 related articles for article (PubMed ID: 38451815)
1. Sequential analysis of cfDNA reveals clonal evolution in neuroblastoma patients receiving ALK targeted therapy.
Bobin C; Iddir Y; Butterworth C; Masliah-Planchon J; Saint-Charles A; Bellini A; Bhalshankar J; Pierron G; Combaret V; Attignon V; André N; Corradini N; Dumont B; Mansuy L; Khanfar C; Klein S; Briandet C; Plantaz D; Millot F; Thouvenin S; Aerts I; Ndounga-Diakou LA; Laghouati S; Abbou S; Jehanno N; Tissot H; Renault S; Baulande S; Raynal V; Bozec L; Bieche I; Delattre O; Berlanga P; Schleiermacher G
Clin Cancer Res; 2024 May; ():. PubMed ID: 38787533
[TBL] [Abstract][Full Text] [Related]
2. Cell Proliferation in Neuroblastoma.
Stafman LL; Beierle EA
Cancers (Basel); 2016 Jan; 8(1):. PubMed ID: 26771642
[TBL] [Abstract][Full Text] [Related]
3. Biological categories of neuroblastoma based on the international neuroblastoma pathology classification for treatment stratification.
Nakazawa A
Pathol Int; 2021 Apr; 71(4):232-244. PubMed ID: 33657257
[TBL] [Abstract][Full Text] [Related]
4. Emerging importance of ALK in neuroblastoma.
Azarova AM; Gautam G; George RE
Semin Cancer Biol; 2011 Oct; 21(4):267-75. PubMed ID: 21945349
[TBL] [Abstract][Full Text] [Related]
5. ALK upregulates POSTN and WNT signaling to drive neuroblastoma.
Huang M; Fang W; Farrel A; Li L; Chronopoulos A; Nasholm N; Cheng B; Zheng T; Yoda H; Barata MJ; Porras T; Miller ML; Zhen Q; Ghiglieri L; McHenry L; Wang L; Asgharzadeh S; Park J; Gustafson WC; Matthay KK; Maris JM; Weiss WA
Cell Rep; 2024 Mar; 43(3):113927. PubMed ID: 38451815
[TBL] [Abstract][Full Text] [Related]
6. Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.
Kramer M; Ribeiro D; Arsenian-Henriksson M; Deller T; Rohrer H
J Neurosci; 2016 Oct; 36(40):10425-10439. PubMed ID: 27707976
[TBL] [Abstract][Full Text] [Related]
7. Activated ALK Cooperates with N-Myc via Wnt/β-Catenin Signaling to Induce Neuroendocrine Prostate Cancer.
Unno K; Chalmers ZR; Pamarthy S; Vatapalli R; Rodriguez Y; Lysy B; Mok H; Sagar V; Han H; Yoo YA; Ku SY; Beltran H; Zhao Y; Abdulkadir SA
Cancer Res; 2021 Apr; 81(8):2157-2170. PubMed ID: 33637566
[TBL] [Abstract][Full Text] [Related]
8. The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma.
Berry T; Luther W; Bhatnagar N; Jamin Y; Poon E; Sanda T; Pei D; Sharma B; Vetharoy WR; Hallsworth A; Ahmad Z; Barker K; Moreau L; Webber H; Wang W; Liu Q; Perez-Atayde A; Rodig S; Cheung NK; Raynaud F; Hallberg B; Robinson SP; Gray NS; Pearson AD; Eccles SA; Chesler L; George RE
Cancer Cell; 2012 Jul; 22(1):117-30. PubMed ID: 22789543
[TBL] [Abstract][Full Text] [Related]
9. The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH-MYCN transgenic neuroblastoma mouse model.
Lu J; Guan S; Zhao Y; Yu Y; Woodfield SE; Zhang H; Yang KL; Bieerkehazhi S; Qi L; Li X; Gu J; Xu X; Jin J; Muscal JA; Yang T; Xu GT; Yang J
Cancer Lett; 2017 Aug; 400():61-68. PubMed ID: 28455243
[TBL] [Abstract][Full Text] [Related]
10. Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma.
Moore NF; Azarova AM; Bhatnagar N; Ross KN; Drake LE; Frumm S; Liu QS; Christie AL; Sanda T; Chesler L; Kung AL; Gray NS; Stegmaier K; George RE
Oncotarget; 2014 Sep; 5(18):8737-49. PubMed ID: 25228590
[TBL] [Abstract][Full Text] [Related]
11. Periostin: an emerging activator of multiple signaling pathways.
Wang Z; An J; Zhu D; Chen H; Lin A; Kang J; Liu W; Kang X
J Cell Commun Signal; 2022 Dec; 16(4):515-530. PubMed ID: 35412260
[TBL] [Abstract][Full Text] [Related]
12. Human embryonic stem cell-derived neural crest model unveils CD55 as a cancer stem cell regulator for therapeutic targeting in MYCN-amplified neuroblastoma.
Weng Z; Lin J; He J; Gao L; Lin S; Tsang LL; Zhang H; He X; Wang G; Yang X; Zhou H; Zhao H; Li G; Zou L; Jiang X
Neuro Oncol; 2022 Jun; 24(6):872-885. PubMed ID: 34655293
[TBL] [Abstract][Full Text] [Related]
13. Gene Set Knowledge Discovery with Enrichr.
Xie Z; Bailey A; Kuleshov MV; Clarke DJB; Evangelista JE; Jenkins SL; Lachmann A; Wojciechowicz ML; Kropiwnicki E; Jagodnik KM; Jeon M; Ma'ayan A
Curr Protoc; 2021 Mar; 1(3):e90. PubMed ID: 33780170
[TBL] [Abstract][Full Text] [Related]
14. Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma.
Jansky S; Sharma AK; Körber V; Quintero A; Toprak UH; Wecht EM; Gartlgruber M; Greco A; Chomsky E; Grünewald TGP; Henrich KO; Tanay A; Herrmann C; Höfer T; Westermann F
Nat Genet; 2021 May; 53(5):683-693. PubMed ID: 33767450
[TBL] [Abstract][Full Text] [Related]
15. An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays.
Suarez-Arnedo A; Torres Figueroa F; Clavijo C; Arbeláez P; Cruz JC; Muñoz-Camargo C
PLoS One; 2020; 15(7):e0232565. PubMed ID: 32722676
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
